KTRA (Kintara Therapeutics) Net earnings per share growth this year

KTRA (Kintara Pharma) - company brandmark

Kintara Therapeutics (KTRA) is developing unique methods to combat severe brain injuries, leveraging patented protections to ensure high margins. The percentage deviation of EPS from last year's level reflects the dynamics of these processes, with the current value standing at 15.20. Patients value Kintara Therapeutics for providing lifelines in critical cases, while the current asset merger strengthens the long-term confidence of the professional community.

Earnings per share growth in current year: Kintara Therapeutics Inc (KTRA) for 07/04/2022 - 11/17/2026

Financial and market metric breakdowns for kintara.com (KTRA)

- stock quotes and analyst forecast:
Summary company analysis:KTRA Kintara Therapeutics
Signature product of Kintara Therapeutics

Investors utilize profit dynamics to verify the issuer's financial stability and assess the quality of capital management. The annual growth of net income per share measures the percentage deviation of the current EPS from the same period last year, promptly capturing profitability inflection points. For Kintara Therapeutics (KTRA), this indicator determines whether the ownership of unique assets in brain cancer therapy is transforming into actual cash flow.

Key competitors

Earnings per share growth this year INCY|Earnings per share growth in current year Hutchison MediPharma|Net earnings per share growth this year nuvationbio.com (NUVB)|Earnings per share growth in current year Day One Biopharmaceuticals Inc (DAWN)|MNPR - Earnings per share growth rate in current year|Earnings per share growth in current year Inhibrx Biosciences Inc INBX|I-Mab - Earnings per share growth in current year|FENC - Earnings per share growth in current year|Earnings per share growth rate in current year herontx.com|NVCT: Earnings growth in current year|Net earnings per share change in current year Coherus CHRS|Net earnings per share growth this year CRBP|Earnings per share growth rate in current year Cardiff Oncology CRDF|Net earnings per share growth this year BYSI (BeyondSpring Inc.)|BCAB (BioAtla Corp) - Earnings per share increase in current year|Lixte Biotechnology - Net earnings per share growth this year|Net earnings per one share growth for the current year CTXR (Citius Pharma)|Cellectar - Earnings growth in current year|Earnings per share increase in current year BLRX (BioLineRx Corp)|CANF: Earnings growth in current year|Earnings per share growth rate in current year Aprea (APRE)|Earnings per share growth in current year kaziatherapeutics.com|SLXN: Earnings per share increase in current year|Earnings growth in current year NCNA|Earnings growth in current year Chimerix Inc (CMRX)|Earnings per share growth in current year Cyclacel Pharmaceuticals Inc. CYCC|GTHX (g1therapeutics.com) - Earnings per share trend in current year|KRON: Net earnings per share growth this year|Earnings per share growth rate in current year Oncternal Therapeutics Inc|Portage Biotech (PRTG) - Earnings per share growth in current year